Literature DB >> 17329738

Phenotypic and genetic complexity of psychosis. Invited commentary on ... Schizophrenia: a common disease caused by multiple rare alleles.

Nick Craddock1, Michael C O'Donovan, Michael J Owen.   

Abstract

Psychosis, like other major psychiatric disorders, is both genetically and clinically complex. Increasingly powerful molecular genetic studies have the potential to identify DNA variation that influences susceptibility to genetically complex disorders. There is a need to use a range of genetic approaches appropriate to identifying a spectrum of risk variants from the common through to the rare. Some variants might have large effects at the level of the individual but most are likely to have modest or small effects at both population and individual level. Extensive clinical heterogeneity is likely to have a significant impact on the power of even the largest studies and, more importantly, will lead to extensive variability between studies and hamper attempts at replication. If we are to realise the potential of molecular genetics, we need to overcome the major limitations imposed by current psychiatric diagnostic classifications and identify clinical phenotypes that reflect the presence of underlying entities with biological validity.

Entities:  

Mesh:

Year:  2007        PMID: 17329738     DOI: 10.1192/bjp.bp.106.033761

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  27 in total

Review 1.  Five years of GWAS discovery.

Authors:  Peter M Visscher; Matthew A Brown; Mark I McCarthy; Jian Yang
Journal:  Am J Hum Genet       Date:  2012-01-13       Impact factor: 11.025

2.  The final common pathway of schizophrenia.

Authors:  Peter Williamson
Journal:  Schizophr Bull       Date:  2007-05-24       Impact factor: 9.306

Review 3.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

4.  Linkage analysis of schizophrenia controlling for population substructure.

Authors:  Tiina Paunio; Ritva Arajärvi; Joseph D Terwilliger; Tero Hiekkalinna; Perttu Haimi; Timo Partonen; Jouko Lönnqvist; Leena Peltonen; Teppo Varilo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-09-05       Impact factor: 3.568

Review 5.  Ten good reasons to consider biological processes in prevention and intervention research.

Authors:  Theodore P Beauchaine; Emily Neuhaus; Sharon L Brenner; Lisa Gatzke-Kopp
Journal:  Dev Psychopathol       Date:  2008

6.  A common haplotype of DRD3 affected by recent positive selection is associated with protection from schizophrenia.

Authors:  Javier Costas; Noa Carrera; Eduardo Domínguez; Elisabet Vilella; Lourdes Martorell; Joaquín Valero; Alfonso Gutiérrez-Zotes; Antonio Labad; Angel Carracedo
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

7.  Brief report: no association between premorbid adjustment in adult-onset schizophrenia and genetic variation in Dysbindin.

Authors:  Frederike Schirmbeck; Alexander Georgi; Jana Strohmaier; Christine Schmael; Katja V Boesshenz; Thomas W Mühleisen; Stefan Herms; Per Hoffmann; Rami Abou Jamra; Johannes Schumacher; Wolfgang Maier; Peter Propping; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Thomas G Schulze
Journal:  J Autism Dev Disord       Date:  2008-05-13

8.  Genome-wide association studies: a primer.

Authors:  A Corvin; N Craddock; P F Sullivan
Journal:  Psychol Med       Date:  2009-11-09       Impact factor: 7.723

9.  Genetic variation in neuregulin1 is associated with differences in prefrontal engagement in children.

Authors:  Andrea Mechelli; Essi Viding; William Pettersson-Yeo; Stefania Tognin; Philip K McGuire
Journal:  Hum Brain Mapp       Date:  2009-12       Impact factor: 5.038

10.  Genetic and functional analysis of the DLG4 gene encoding the post-synaptic density protein 95 in schizophrenia.

Authors:  Min-Chih Cheng; Chao-Lin Lu; Sy-Ueng Luu; Ho-Min Tsai; Shih-Hsin Hsu; Tzu-Ting Chen; Chia-Hsiang Chen
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.